Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001578850-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-01-06 | 2026-01-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | A - Grant | $0.00 | +520 | 6,956 | +8% | $0 |
| D | 2026-01-06 | 2026-01-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | A - Grant | $0.00 | +17.5K | 118.4K | +17% | $0 |
| D | 2026-01-06 | 2026-01-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | A - Grant | $0.00 | +43.8K | 43.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | A | A | 520 | $0.00 | 6,956 | I By Spouse | — | — | (F1) Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027. (F2) Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025. |
| 2 | Common | Common Stock | 2026-01-02 | A | A | 17,500 | $0.00 | 118,382 | D | — | — | (F1) Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027. (F2) Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-01-02 | A | A | 43,750 | $0.00 | 43,750 | D | $76.74 · — to 2036-01-01 | 43,750 Common Stock | (F3) This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027. |